The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patients

BACKGROUND: The optimal antiplatelet regimen after in-coronary intervention among patients presenting with complex coronary artery lesions or acute coronary syndrome (ACS) has remained unclear. This study sought to evaluate the clinical outcomes of triple antiplatelet treatment (TAPT) (cilostazol ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Zhong-Guo, Ding, Guo-Bin, Li, Xiao-Bo, Gao, Xiao-Fei, Gao, Ya-Li, Tian, Nai-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076804/
https://www.ncbi.nlm.nih.gov/pubmed/27799743
http://dx.doi.org/10.2147/DDDT.S119616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076804/
https://www.ncbi.nlm.nih.gov/pubmed/27799743
http://dx.doi.org/10.2147/DDDT.S119616

Ejemplares similares